nodes	percent_of_prediction	percent_of_DWPC	metapath
Pioglitazone—PTGS1—Etoposide—sarcoma	0.126	0.269	CbGbCtD
Pioglitazone—CYP3A4—Thiotepa—sarcoma	0.109	0.233	CbGbCtD
Pioglitazone—CYP2C8—Etoposide—sarcoma	0.0728	0.156	CbGbCtD
Pioglitazone—CYP3A4—Mitoxantrone—sarcoma	0.0468	0.1	CbGbCtD
Pioglitazone—CYP3A4—Vincristine—sarcoma	0.0322	0.0688	CbGbCtD
Pioglitazone—CYP2D6—Doxorubicin—sarcoma	0.0317	0.0676	CbGbCtD
Pioglitazone—CYP3A4—Etoposide—sarcoma	0.0295	0.0631	CbGbCtD
Pioglitazone—PPARG—dermis—sarcoma	0.0208	0.115	CbGeAlD
Pioglitazone—CYP3A4—Doxorubicin—sarcoma	0.0201	0.043	CbGbCtD
Pioglitazone—PPARG—periosteum—sarcoma	0.0173	0.0952	CbGeAlD
Pioglitazone—PPARG—leg—sarcoma	0.0138	0.0759	CbGeAlD
Pioglitazone—PPARG—forelimb—sarcoma	0.0137	0.0753	CbGeAlD
Pioglitazone—PPARG—hindlimb—sarcoma	0.0123	0.0678	CbGeAlD
Pioglitazone—PPARG—appendage—sarcoma	0.0105	0.0581	CbGeAlD
Pioglitazone—PPARG—Teniposide—Etoposide—sarcoma	0.00994	1	CbGdCrCtD
Pioglitazone—PPARG—endothelium—sarcoma	0.00636	0.0351	CbGeAlD
Pioglitazone—SLCO1B1—mammary gland—sarcoma	0.00594	0.0328	CbGeAlD
Pioglitazone—PPARG—mammary gland—sarcoma	0.00513	0.0283	CbGeAlD
Pioglitazone—SLCO1B1—hematopoietic system—sarcoma	0.00362	0.02	CbGeAlD
Pioglitazone—PPARG—embryo—sarcoma	0.0035	0.0193	CbGeAlD
Pioglitazone—PTGS1—endothelium—sarcoma	0.0034	0.0188	CbGeAlD
Pioglitazone—CYP2C8—mammary gland—sarcoma	0.00338	0.0186	CbGeAlD
Pioglitazone—SLCO1B3—liver—sarcoma	0.00324	0.0179	CbGeAlD
Pioglitazone—PPARG—hematopoietic system—sarcoma	0.00312	0.0172	CbGeAlD
Pioglitazone—PPARG—connective tissue—sarcoma	0.00301	0.0166	CbGeAlD
Pioglitazone—CYP2C9—mammary gland—sarcoma	0.003	0.0166	CbGeAlD
Pioglitazone—PPARG—smooth muscle tissue—sarcoma	0.00275	0.0152	CbGeAlD
Pioglitazone—PPARG—skin of body—sarcoma	0.00272	0.015	CbGeAlD
Pioglitazone—PPARG—uterus—sarcoma	0.00236	0.013	CbGeAlD
Pioglitazone—CYP2C19—hematopoietic system—sarcoma	0.00236	0.013	CbGeAlD
Pioglitazone—PPARG—lymphoid tissue—sarcoma	0.0022	0.0121	CbGeAlD
Pioglitazone—PPARG—tendon—sarcoma	0.00207	0.0114	CbGeAlD
Pioglitazone—CYP2C8—hematopoietic system—sarcoma	0.00206	0.0114	CbGeAlD
Pioglitazone—PPARG—bone marrow—sarcoma	0.002	0.011	CbGeAlD
Pioglitazone—SLCO1B1—liver—sarcoma	0.00188	0.0103	CbGeAlD
Pioglitazone—CYP2C9—hematopoietic system—sarcoma	0.00183	0.0101	CbGeAlD
Pioglitazone—PTGS1—seminal vesicle—sarcoma	0.00176	0.00969	CbGeAlD
Pioglitazone—PPARG—testis—sarcoma	0.00171	0.00944	CbGeAlD
Pioglitazone—PTGS1—hematopoietic system—sarcoma	0.00167	0.00921	CbGeAlD
Pioglitazone—PPARG—liver—sarcoma	0.00162	0.00893	CbGeAlD
Pioglitazone—PTGS1—connective tissue—sarcoma	0.00161	0.00887	CbGeAlD
Pioglitazone—PTGS1—smooth muscle tissue—sarcoma	0.00147	0.00811	CbGeAlD
Pioglitazone—PTGS1—skin of body—sarcoma	0.00145	0.00801	CbGeAlD
Pioglitazone—CYP3A4—hematopoietic system—sarcoma	0.00139	0.00769	CbGeAlD
Pioglitazone—CYP2D6—hematopoietic system—sarcoma	0.00137	0.00757	CbGeAlD
Pioglitazone—PTGS1—cardiac atrium—sarcoma	0.00127	0.00699	CbGeAlD
Pioglitazone—PTGS1—uterus—sarcoma	0.00126	0.00696	CbGeAlD
Pioglitazone—PPARG—lymph node—sarcoma	0.00124	0.00684	CbGeAlD
Pioglitazone—CYP2C19—liver—sarcoma	0.00122	0.00674	CbGeAlD
Pioglitazone—Myocardial infarction—Etoposide—sarcoma	0.00122	0.00358	CcSEcCtD
Pioglitazone—Malaise—Dactinomycin—sarcoma	0.00121	0.00355	CcSEcCtD
Pioglitazone—Fluid retention—Epirubicin—sarcoma	0.00118	0.00347	CcSEcCtD
Pioglitazone—Hypertension—Thiotepa—sarcoma	0.00117	0.00343	CcSEcCtD
Pioglitazone—Back pain—Vincristine—sarcoma	0.00116	0.0034	CcSEcCtD
Pioglitazone—Arthralgia—Thiotepa—sarcoma	0.00115	0.00338	CcSEcCtD
Pioglitazone—Myalgia—Thiotepa—sarcoma	0.00115	0.00338	CcSEcCtD
Pioglitazone—Cramps of lower extremities—Epirubicin—sarcoma	0.00114	0.00336	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—sarcoma	0.00114	0.00336	CcSEcCtD
Pioglitazone—Myalgia—Dactinomycin—sarcoma	0.00114	0.00335	CcSEcCtD
Pioglitazone—Back pain—Mitoxantrone—sarcoma	0.00113	0.00332	CcSEcCtD
Pioglitazone—CYP2C8—testis—sarcoma	0.00113	0.00622	CbGeAlD
Pioglitazone—Discomfort—Dactinomycin—sarcoma	0.00113	0.00331	CcSEcCtD
Pioglitazone—Neoplasm—Epirubicin—sarcoma	0.00113	0.00331	CcSEcCtD
Pioglitazone—Hypoaesthesia—Etoposide—sarcoma	0.00111	0.00326	CcSEcCtD
Pioglitazone—Pulmonary oedema—Epirubicin—sarcoma	0.00111	0.00325	CcSEcCtD
Pioglitazone—Anaemia—Vincristine—sarcoma	0.00111	0.00325	CcSEcCtD
Pioglitazone—PTGS1—tendon—sarcoma	0.00111	0.0061	CbGeAlD
Pioglitazone—Urinary tract disorder—Etoposide—sarcoma	0.0011	0.00323	CcSEcCtD
Pioglitazone—Infection—Thiotepa—sarcoma	0.0011	0.00322	CcSEcCtD
Pioglitazone—Oedema—Dactinomycin—sarcoma	0.00109	0.00322	CcSEcCtD
Pioglitazone—Fluid retention—Doxorubicin—sarcoma	0.00109	0.00321	CcSEcCtD
Pioglitazone—Urethral disorder—Etoposide—sarcoma	0.00109	0.00321	CcSEcCtD
Pioglitazone—Infection—Dactinomycin—sarcoma	0.00109	0.00319	CcSEcCtD
Pioglitazone—Abnormal vision—Epirubicin—sarcoma	0.00109	0.00319	CcSEcCtD
Pioglitazone—Ill-defined disorder—Mitoxantrone—sarcoma	0.00108	0.00318	CcSEcCtD
Pioglitazone—Nervous system disorder—Thiotepa—sarcoma	0.00108	0.00318	CcSEcCtD
Pioglitazone—Anaemia—Mitoxantrone—sarcoma	0.00108	0.00317	CcSEcCtD
Pioglitazone—Vertigo—Vincristine—sarcoma	0.00108	0.00316	CcSEcCtD
Pioglitazone—Skin disorder—Thiotepa—sarcoma	0.00107	0.00315	CcSEcCtD
Pioglitazone—CYP2C8—liver—sarcoma	0.00107	0.00588	CbGeAlD
Pioglitazone—Cramps of lower extremities—Doxorubicin—sarcoma	0.00106	0.00311	CcSEcCtD
Pioglitazone—Malaise—Mitoxantrone—sarcoma	0.00105	0.00309	CcSEcCtD
Pioglitazone—Eye disorder—Etoposide—sarcoma	0.00104	0.00306	CcSEcCtD
Pioglitazone—Neoplasm—Doxorubicin—sarcoma	0.00104	0.00306	CcSEcCtD
Pioglitazone—Diabetes mellitus—Epirubicin—sarcoma	0.00104	0.00305	CcSEcCtD
Pioglitazone—Cardiac disorder—Etoposide—sarcoma	0.00104	0.00304	CcSEcCtD
Pioglitazone—Hypertension—Vincristine—sarcoma	0.00103	0.00304	CcSEcCtD
Pioglitazone—Pulmonary oedema—Doxorubicin—sarcoma	0.00103	0.00301	CcSEcCtD
Pioglitazone—Myalgia—Vincristine—sarcoma	0.00102	0.003	CcSEcCtD
Pioglitazone—Hypertension—Mitoxantrone—sarcoma	0.00101	0.00296	CcSEcCtD
Pioglitazone—Immune system disorder—Etoposide—sarcoma	0.00101	0.00296	CcSEcCtD
Pioglitazone—Hepatic failure—Epirubicin—sarcoma	0.00101	0.00295	CcSEcCtD
Pioglitazone—Mediastinal disorder—Etoposide—sarcoma	0.00101	0.00295	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Thiotepa—sarcoma	0.00101	0.00295	CcSEcCtD
Pioglitazone—Abnormal vision—Doxorubicin—sarcoma	0.001	0.00295	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Dactinomycin—sarcoma	0.000997	0.00293	CcSEcCtD
Pioglitazone—Cardiac failure congestive—Epirubicin—sarcoma	0.000997	0.00293	CcSEcCtD
Pioglitazone—Chest pain—Mitoxantrone—sarcoma	0.000994	0.00292	CcSEcCtD
Pioglitazone—Myalgia—Mitoxantrone—sarcoma	0.000994	0.00292	CcSEcCtD
Pioglitazone—Arthralgia—Mitoxantrone—sarcoma	0.000994	0.00292	CcSEcCtD
Pioglitazone—Discomfort—Mitoxantrone—sarcoma	0.000982	0.00288	CcSEcCtD
Pioglitazone—Anaphylactic shock—Vincristine—sarcoma	0.000978	0.00287	CcSEcCtD
Pioglitazone—Oedema—Vincristine—sarcoma	0.000978	0.00287	CcSEcCtD
Pioglitazone—Infection—Vincristine—sarcoma	0.000972	0.00285	CcSEcCtD
Pioglitazone—Increased appetite—Epirubicin—sarcoma	0.000962	0.00282	CcSEcCtD
Pioglitazone—Diabetes mellitus—Doxorubicin—sarcoma	0.000961	0.00282	CcSEcCtD
Pioglitazone—Nervous system disorder—Vincristine—sarcoma	0.000959	0.00282	CcSEcCtD
Pioglitazone—Oedema—Mitoxantrone—sarcoma	0.000953	0.0028	CcSEcCtD
Pioglitazone—Anaphylactic shock—Mitoxantrone—sarcoma	0.000953	0.0028	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Thiotepa—sarcoma	0.000952	0.0028	CcSEcCtD
Pioglitazone—Fatigue—Thiotepa—sarcoma	0.000951	0.00279	CcSEcCtD
Pioglitazone—CYP2C9—liver—sarcoma	0.000948	0.00523	CbGeAlD
Pioglitazone—Infection—Mitoxantrone—sarcoma	0.000946	0.00278	CcSEcCtD
Pioglitazone—Hyperhidrosis—Vincristine—sarcoma	0.000946	0.00278	CcSEcCtD
Pioglitazone—Fatigue—Dactinomycin—sarcoma	0.000944	0.00277	CcSEcCtD
Pioglitazone—Back pain—Etoposide—sarcoma	0.000939	0.00276	CcSEcCtD
Pioglitazone—Muscle spasms—Etoposide—sarcoma	0.000933	0.00274	CcSEcCtD
Pioglitazone—Hepatic failure—Doxorubicin—sarcoma	0.00093	0.00273	CcSEcCtD
Pioglitazone—Cardiac failure—Epirubicin—sarcoma	0.000926	0.00272	CcSEcCtD
Pioglitazone—Hypoglycaemia—Epirubicin—sarcoma	0.000926	0.00272	CcSEcCtD
Pioglitazone—Skin disorder—Mitoxantrone—sarcoma	0.000925	0.00272	CcSEcCtD
Pioglitazone—Cerebrovascular accident—Epirubicin—sarcoma	0.000922	0.00271	CcSEcCtD
Pioglitazone—Cardiac failure congestive—Doxorubicin—sarcoma	0.000922	0.00271	CcSEcCtD
Pioglitazone—Hyperhidrosis—Mitoxantrone—sarcoma	0.000921	0.0027	CcSEcCtD
Pioglitazone—PTGS1—testis—sarcoma	0.000915	0.00505	CbGeAlD
Pioglitazone—Feeling abnormal—Thiotepa—sarcoma	0.000909	0.00267	CcSEcCtD
Pioglitazone—Pain in extremity—Epirubicin—sarcoma	0.000904	0.00265	CcSEcCtD
Pioglitazone—Feeling abnormal—Dactinomycin—sarcoma	0.000902	0.00265	CcSEcCtD
Pioglitazone—Ill-defined disorder—Etoposide—sarcoma	0.000901	0.00265	CcSEcCtD
Pioglitazone—Anaemia—Etoposide—sarcoma	0.000897	0.00264	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Vincristine—sarcoma	0.000891	0.00262	CcSEcCtD
Pioglitazone—Increased appetite—Doxorubicin—sarcoma	0.00089	0.00261	CcSEcCtD
Pioglitazone—Insomnia—Vincristine—sarcoma	0.000885	0.0026	CcSEcCtD
Pioglitazone—Urticaria—Thiotepa—sarcoma	0.000876	0.00257	CcSEcCtD
Pioglitazone—Malaise—Etoposide—sarcoma	0.000876	0.00257	CcSEcCtD
Pioglitazone—Vertigo—Etoposide—sarcoma	0.000872	0.00256	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.000868	0.00255	CcSEcCtD
Pioglitazone—Cardiac failure—Doxorubicin—sarcoma	0.000857	0.00252	CcSEcCtD
Pioglitazone—Hypoglycaemia—Doxorubicin—sarcoma	0.000857	0.00252	CcSEcCtD
Pioglitazone—Cerebrovascular accident—Doxorubicin—sarcoma	0.000853	0.00251	CcSEcCtD
Pioglitazone—Dyspnoea—Mitoxantrone—sarcoma	0.000849	0.00249	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Vincristine—sarcoma	0.000845	0.00248	CcSEcCtD
Pioglitazone—Fatigue—Vincristine—sarcoma	0.000843	0.00248	CcSEcCtD
Pioglitazone—Hypertension—Etoposide—sarcoma	0.000838	0.00246	CcSEcCtD
Pioglitazone—Pain in extremity—Doxorubicin—sarcoma	0.000836	0.00246	CcSEcCtD
Pioglitazone—Liver function test abnormal—Epirubicin—sarcoma	0.000834	0.00245	CcSEcCtD
Pioglitazone—Chest pain—Etoposide—sarcoma	0.000827	0.00243	CcSEcCtD
Pioglitazone—Abdominal pain upper—Epirubicin—sarcoma	0.000825	0.00242	CcSEcCtD
Pioglitazone—Fatigue—Mitoxantrone—sarcoma	0.000821	0.00241	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.000821	0.00241	CcSEcCtD
Pioglitazone—Discomfort—Etoposide—sarcoma	0.000817	0.0024	CcSEcCtD
Pioglitazone—Breast disorder—Epirubicin—sarcoma	0.000817	0.0024	CcSEcCtD
Pioglitazone—Hypersensitivity—Thiotepa—sarcoma	0.000813	0.00239	CcSEcCtD
Pioglitazone—Hypersensitivity—Dactinomycin—sarcoma	0.000807	0.00237	CcSEcCtD
Pioglitazone—Alanine aminotransferase increased—Epirubicin—sarcoma	0.000797	0.00234	CcSEcCtD
Pioglitazone—Anaphylactic shock—Etoposide—sarcoma	0.000792	0.00233	CcSEcCtD
Pioglitazone—Asthenia—Thiotepa—sarcoma	0.000791	0.00232	CcSEcCtD
Pioglitazone—Infection—Etoposide—sarcoma	0.000787	0.00231	CcSEcCtD
Pioglitazone—Asthenia—Dactinomycin—sarcoma	0.000786	0.00231	CcSEcCtD
Pioglitazone—Feeling abnormal—Mitoxantrone—sarcoma	0.000785	0.00231	CcSEcCtD
Pioglitazone—Influenza—Epirubicin—sarcoma	0.000781	0.00229	CcSEcCtD
Pioglitazone—Liver function test abnormal—Doxorubicin—sarcoma	0.000772	0.00227	CcSEcCtD
Pioglitazone—Skin disorder—Etoposide—sarcoma	0.00077	0.00226	CcSEcCtD
Pioglitazone—Hyperhidrosis—Etoposide—sarcoma	0.000766	0.00225	CcSEcCtD
Pioglitazone—Abdominal pain upper—Doxorubicin—sarcoma	0.000764	0.00224	CcSEcCtD
Pioglitazone—Angina pectoris—Epirubicin—sarcoma	0.000761	0.00223	CcSEcCtD
Pioglitazone—Urticaria—Mitoxantrone—sarcoma	0.000757	0.00222	CcSEcCtD
Pioglitazone—Breast disorder—Doxorubicin—sarcoma	0.000756	0.00222	CcSEcCtD
Pioglitazone—Diarrhoea—Thiotepa—sarcoma	0.000755	0.00222	CcSEcCtD
Pioglitazone—CYP2D6—testis—sarcoma	0.000752	0.00415	CbGeAlD
Pioglitazone—Bronchitis—Epirubicin—sarcoma	0.000751	0.00221	CcSEcCtD
Pioglitazone—Diarrhoea—Dactinomycin—sarcoma	0.000749	0.0022	CcSEcCtD
Pioglitazone—Alanine aminotransferase increased—Doxorubicin—sarcoma	0.000738	0.00217	CcSEcCtD
Pioglitazone—Dizziness—Thiotepa—sarcoma	0.000729	0.00214	CcSEcCtD
Pioglitazone—Upper respiratory tract infection—Epirubicin—sarcoma	0.000726	0.00213	CcSEcCtD
Pioglitazone—Influenza—Doxorubicin—sarcoma	0.000723	0.00212	CcSEcCtD
Pioglitazone—CYP3A4—liver—sarcoma	0.000723	0.00399	CbGeAlD
Pioglitazone—Hypersensitivity—Vincristine—sarcoma	0.000721	0.00212	CcSEcCtD
Pioglitazone—CYP2D6—liver—sarcoma	0.000711	0.00392	CbGeAlD
Pioglitazone—Weight increased—Epirubicin—sarcoma	0.000711	0.00209	CcSEcCtD
Pioglitazone—Weight decreased—Epirubicin—sarcoma	0.000707	0.00208	CcSEcCtD
Pioglitazone—Dyspnoea—Etoposide—sarcoma	0.000706	0.00207	CcSEcCtD
Pioglitazone—Hyperglycaemia—Epirubicin—sarcoma	0.000705	0.00207	CcSEcCtD
Pioglitazone—Angina pectoris—Doxorubicin—sarcoma	0.000704	0.00207	CcSEcCtD
Pioglitazone—Hypersensitivity—Mitoxantrone—sarcoma	0.000702	0.00206	CcSEcCtD
Pioglitazone—Asthenia—Vincristine—sarcoma	0.000702	0.00206	CcSEcCtD
Pioglitazone—Infestation—Epirubicin—sarcoma	0.000696	0.00205	CcSEcCtD
Pioglitazone—Infestation NOS—Epirubicin—sarcoma	0.000696	0.00205	CcSEcCtD
Pioglitazone—Bronchitis—Doxorubicin—sarcoma	0.000695	0.00204	CcSEcCtD
Pioglitazone—Headache—Thiotepa—sarcoma	0.000691	0.00203	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Etoposide—sarcoma	0.000684	0.00201	CcSEcCtD
Pioglitazone—Asthenia—Mitoxantrone—sarcoma	0.000683	0.00201	CcSEcCtD
Pioglitazone—Fatigue—Etoposide—sarcoma	0.000683	0.00201	CcSEcCtD
Pioglitazone—Urinary tract infection—Epirubicin—sarcoma	0.000677	0.00199	CcSEcCtD
Pioglitazone—Upper respiratory tract infection—Doxorubicin—sarcoma	0.000672	0.00197	CcSEcCtD
Pioglitazone—Diarrhoea—Vincristine—sarcoma	0.000669	0.00197	CcSEcCtD
Pioglitazone—Sweating—Epirubicin—sarcoma	0.000668	0.00196	CcSEcCtD
Pioglitazone—Haematuria—Epirubicin—sarcoma	0.000664	0.00195	CcSEcCtD
Pioglitazone—PTGS1—lymph node—sarcoma	0.000663	0.00366	CbGeAlD
Pioglitazone—Weight increased—Doxorubicin—sarcoma	0.000658	0.00193	CcSEcCtD
Pioglitazone—Weight decreased—Doxorubicin—sarcoma	0.000654	0.00192	CcSEcCtD
Pioglitazone—Sinusitis—Epirubicin—sarcoma	0.000653	0.00192	CcSEcCtD
Pioglitazone—Feeling abnormal—Etoposide—sarcoma	0.000653	0.00192	CcSEcCtD
Pioglitazone—Hyperglycaemia—Doxorubicin—sarcoma	0.000652	0.00191	CcSEcCtD
Pioglitazone—Diarrhoea—Mitoxantrone—sarcoma	0.000652	0.00191	CcSEcCtD
Pioglitazone—Dizziness—Vincristine—sarcoma	0.000647	0.0019	CcSEcCtD
Pioglitazone—Infestation—Doxorubicin—sarcoma	0.000644	0.00189	CcSEcCtD
Pioglitazone—Infestation NOS—Doxorubicin—sarcoma	0.000644	0.00189	CcSEcCtD
Pioglitazone—Urticaria—Etoposide—sarcoma	0.000629	0.00185	CcSEcCtD
Pioglitazone—Urinary tract infection—Doxorubicin—sarcoma	0.000626	0.00184	CcSEcCtD
Pioglitazone—Hepatitis—Epirubicin—sarcoma	0.000625	0.00184	CcSEcCtD
Pioglitazone—Hypoaesthesia—Epirubicin—sarcoma	0.000622	0.00183	CcSEcCtD
Pioglitazone—Pharyngitis—Epirubicin—sarcoma	0.000621	0.00182	CcSEcCtD
Pioglitazone—Sweating—Doxorubicin—sarcoma	0.000618	0.00181	CcSEcCtD
Pioglitazone—Urinary tract disorder—Epirubicin—sarcoma	0.000617	0.00181	CcSEcCtD
Pioglitazone—Oedema peripheral—Epirubicin—sarcoma	0.000616	0.00181	CcSEcCtD
Pioglitazone—Haematuria—Doxorubicin—sarcoma	0.000614	0.0018	CcSEcCtD
Pioglitazone—Connective tissue disorder—Epirubicin—sarcoma	0.000614	0.0018	CcSEcCtD
Pioglitazone—Urethral disorder—Epirubicin—sarcoma	0.000613	0.0018	CcSEcCtD
Pioglitazone—Headache—Vincristine—sarcoma	0.000613	0.0018	CcSEcCtD
Pioglitazone—Sinusitis—Doxorubicin—sarcoma	0.000605	0.00178	CcSEcCtD
Pioglitazone—Visual impairment—Epirubicin—sarcoma	0.000602	0.00177	CcSEcCtD
Pioglitazone—Headache—Mitoxantrone—sarcoma	0.000597	0.00175	CcSEcCtD
Pioglitazone—Eye disorder—Epirubicin—sarcoma	0.000584	0.00172	CcSEcCtD
Pioglitazone—Hypersensitivity—Etoposide—sarcoma	0.000584	0.00171	CcSEcCtD
Pioglitazone—Cardiac disorder—Epirubicin—sarcoma	0.00058	0.0017	CcSEcCtD
Pioglitazone—Hepatitis—Doxorubicin—sarcoma	0.000578	0.0017	CcSEcCtD
Pioglitazone—Hypoaesthesia—Doxorubicin—sarcoma	0.000576	0.00169	CcSEcCtD
Pioglitazone—Pharyngitis—Doxorubicin—sarcoma	0.000574	0.00169	CcSEcCtD
Pioglitazone—Urinary tract disorder—Doxorubicin—sarcoma	0.000571	0.00168	CcSEcCtD
Pioglitazone—Oedema peripheral—Doxorubicin—sarcoma	0.00057	0.00167	CcSEcCtD
Pioglitazone—Asthenia—Etoposide—sarcoma	0.000569	0.00167	CcSEcCtD
Pioglitazone—Connective tissue disorder—Doxorubicin—sarcoma	0.000568	0.00167	CcSEcCtD
Pioglitazone—Urethral disorder—Doxorubicin—sarcoma	0.000567	0.00167	CcSEcCtD
Pioglitazone—Immune system disorder—Epirubicin—sarcoma	0.000565	0.00166	CcSEcCtD
Pioglitazone—Mediastinal disorder—Epirubicin—sarcoma	0.000563	0.00165	CcSEcCtD
Pioglitazone—Visual impairment—Doxorubicin—sarcoma	0.000557	0.00164	CcSEcCtD
Pioglitazone—Malnutrition—Epirubicin—sarcoma	0.000544	0.0016	CcSEcCtD
Pioglitazone—Diarrhoea—Etoposide—sarcoma	0.000542	0.00159	CcSEcCtD
Pioglitazone—Eye disorder—Doxorubicin—sarcoma	0.000541	0.00159	CcSEcCtD
Pioglitazone—Cardiac disorder—Doxorubicin—sarcoma	0.000537	0.00158	CcSEcCtD
Pioglitazone—Flatulence—Epirubicin—sarcoma	0.000536	0.00157	CcSEcCtD
Pioglitazone—Back pain—Epirubicin—sarcoma	0.000526	0.00155	CcSEcCtD
Pioglitazone—Dizziness—Etoposide—sarcoma	0.000524	0.00154	CcSEcCtD
Pioglitazone—Muscle spasms—Epirubicin—sarcoma	0.000523	0.00154	CcSEcCtD
Pioglitazone—Immune system disorder—Doxorubicin—sarcoma	0.000523	0.00153	CcSEcCtD
Pioglitazone—Mediastinal disorder—Doxorubicin—sarcoma	0.000521	0.00153	CcSEcCtD
Pioglitazone—Ill-defined disorder—Epirubicin—sarcoma	0.000505	0.00148	CcSEcCtD
Pioglitazone—Malnutrition—Doxorubicin—sarcoma	0.000504	0.00148	CcSEcCtD
Pioglitazone—Anaemia—Epirubicin—sarcoma	0.000503	0.00148	CcSEcCtD
Pioglitazone—Headache—Etoposide—sarcoma	0.000496	0.00146	CcSEcCtD
Pioglitazone—Flatulence—Doxorubicin—sarcoma	0.000496	0.00146	CcSEcCtD
Pioglitazone—Malaise—Epirubicin—sarcoma	0.000491	0.00144	CcSEcCtD
Pioglitazone—Vertigo—Epirubicin—sarcoma	0.000489	0.00144	CcSEcCtD
Pioglitazone—Back pain—Doxorubicin—sarcoma	0.000487	0.00143	CcSEcCtD
Pioglitazone—Muscle spasms—Doxorubicin—sarcoma	0.000484	0.00142	CcSEcCtD
Pioglitazone—Hypertension—Epirubicin—sarcoma	0.00047	0.00138	CcSEcCtD
Pioglitazone—Ill-defined disorder—Doxorubicin—sarcoma	0.000467	0.00137	CcSEcCtD
Pioglitazone—Anaemia—Doxorubicin—sarcoma	0.000465	0.00137	CcSEcCtD
Pioglitazone—Chest pain—Epirubicin—sarcoma	0.000463	0.00136	CcSEcCtD
Pioglitazone—Arthralgia—Epirubicin—sarcoma	0.000463	0.00136	CcSEcCtD
Pioglitazone—Myalgia—Epirubicin—sarcoma	0.000463	0.00136	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.00046	0.00135	CcSEcCtD
Pioglitazone—Discomfort—Epirubicin—sarcoma	0.000458	0.00134	CcSEcCtD
Pioglitazone—Malaise—Doxorubicin—sarcoma	0.000454	0.00133	CcSEcCtD
Pioglitazone—Vertigo—Doxorubicin—sarcoma	0.000452	0.00133	CcSEcCtD
Pioglitazone—Anaphylactic shock—Epirubicin—sarcoma	0.000444	0.0013	CcSEcCtD
Pioglitazone—Oedema—Epirubicin—sarcoma	0.000444	0.0013	CcSEcCtD
Pioglitazone—Infection—Epirubicin—sarcoma	0.000441	0.0013	CcSEcCtD
Pioglitazone—Nervous system disorder—Epirubicin—sarcoma	0.000436	0.00128	CcSEcCtD
Pioglitazone—Hypertension—Doxorubicin—sarcoma	0.000435	0.00128	CcSEcCtD
Pioglitazone—Skin disorder—Epirubicin—sarcoma	0.000431	0.00127	CcSEcCtD
Pioglitazone—Hyperhidrosis—Epirubicin—sarcoma	0.000429	0.00126	CcSEcCtD
Pioglitazone—Myalgia—Doxorubicin—sarcoma	0.000429	0.00126	CcSEcCtD
Pioglitazone—Arthralgia—Doxorubicin—sarcoma	0.000429	0.00126	CcSEcCtD
Pioglitazone—Chest pain—Doxorubicin—sarcoma	0.000429	0.00126	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000426	0.00125	CcSEcCtD
Pioglitazone—Discomfort—Doxorubicin—sarcoma	0.000424	0.00124	CcSEcCtD
Pioglitazone—Anaphylactic shock—Doxorubicin—sarcoma	0.000411	0.00121	CcSEcCtD
Pioglitazone—Oedema—Doxorubicin—sarcoma	0.000411	0.00121	CcSEcCtD
Pioglitazone—Infection—Doxorubicin—sarcoma	0.000408	0.0012	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000405	0.00119	CcSEcCtD
Pioglitazone—Nervous system disorder—Doxorubicin—sarcoma	0.000403	0.00118	CcSEcCtD
Pioglitazone—Insomnia—Epirubicin—sarcoma	0.000402	0.00118	CcSEcCtD
Pioglitazone—Skin disorder—Doxorubicin—sarcoma	0.000399	0.00117	CcSEcCtD
Pioglitazone—Hyperhidrosis—Doxorubicin—sarcoma	0.000397	0.00117	CcSEcCtD
Pioglitazone—Dyspnoea—Epirubicin—sarcoma	0.000396	0.00116	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Epirubicin—sarcoma	0.000383	0.00113	CcSEcCtD
Pioglitazone—Fatigue—Epirubicin—sarcoma	0.000383	0.00112	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000374	0.0011	CcSEcCtD
Pioglitazone—Insomnia—Doxorubicin—sarcoma	0.000372	0.00109	CcSEcCtD
Pioglitazone—Dyspnoea—Doxorubicin—sarcoma	0.000366	0.00108	CcSEcCtD
Pioglitazone—Feeling abnormal—Epirubicin—sarcoma	0.000366	0.00107	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000355	0.00104	CcSEcCtD
Pioglitazone—Fatigue—Doxorubicin—sarcoma	0.000354	0.00104	CcSEcCtD
Pioglitazone—Urticaria—Epirubicin—sarcoma	0.000353	0.00104	CcSEcCtD
Pioglitazone—Feeling abnormal—Doxorubicin—sarcoma	0.000339	0.000995	CcSEcCtD
Pioglitazone—Hypersensitivity—Epirubicin—sarcoma	0.000327	0.000961	CcSEcCtD
Pioglitazone—Urticaria—Doxorubicin—sarcoma	0.000326	0.000959	CcSEcCtD
Pioglitazone—Asthenia—Epirubicin—sarcoma	0.000319	0.000936	CcSEcCtD
Pioglitazone—Diarrhoea—Epirubicin—sarcoma	0.000304	0.000893	CcSEcCtD
Pioglitazone—Hypersensitivity—Doxorubicin—sarcoma	0.000303	0.000889	CcSEcCtD
Pioglitazone—Asthenia—Doxorubicin—sarcoma	0.000295	0.000866	CcSEcCtD
Pioglitazone—Dizziness—Epirubicin—sarcoma	0.000294	0.000863	CcSEcCtD
Pioglitazone—Diarrhoea—Doxorubicin—sarcoma	0.000281	0.000826	CcSEcCtD
Pioglitazone—Headache—Epirubicin—sarcoma	0.000278	0.000817	CcSEcCtD
Pioglitazone—Dizziness—Doxorubicin—sarcoma	0.000272	0.000798	CcSEcCtD
Pioglitazone—Headache—Doxorubicin—sarcoma	0.000257	0.000756	CcSEcCtD
